default author photo

Wei Xue

Shanghai Jiao Tong University (SJTU)

SCHOLARLY PAPERS

2

DOWNLOADS

89

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Tislelizumab Plus Lenvatinib as the First-Line Therapy in Patients with Advanced Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Single-Arm, Single-Centre, Phase 2 Trial and Metabolic Biomarker Analysis

Number of pages: 33 Posted: 07 Oct 2025
Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU) - Department of Urology, Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU) - Department of Urology, Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU) - Department of Radiology, Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU) and Shanghai Jiao Tong University (SJTU)
Downloads 48 (1,109,210)

Abstract:

Loading...

Fumarate hydratase-deficient renal cell carcinoma, immune checkpoint inhibitor, tyrosine kinase inhibitor, succinate-modifying metabolites

2.

Am-Lcnet: A Novel Model Fusing Lstm and Cursor-Cnn Through an Attention Mechanism for Raman Spectroscopy Assisted Diagnosis — Improving Diagnostic Accuracy for Prostate Cancer

Number of pages: 19 Posted: 23 Jan 2025
affiliation not provided to SSRN, Shanghai University, Shanghai University, Shanghai University, affiliation not provided to SSRN, Shanghai University and Shanghai Jiao Tong University (SJTU)
Downloads 41 (1,170,409)
Citation 1

Abstract:

Loading...

Raman Spectroscopy, Intelligent assisted disease diagnosis, Prostate Cancer, Feature fusion